Austin Heart Research

Center Information

Benjamin Vouk
Clinical Research Director
Austin Heart Research
3801 N. Lamar Blvd., Suite 300
Austin, TX 78751


Currently Enrolling Trials

[Show More]

Therapeutic Areas

Cardiology/Vascular Diseases
Internal Medicine
Trauma (Emergency, Injury, Surgery)

Performance Metrics

Number of Studies Conducted: 200+
Number of Active Patients in the Database: 50,000+
Average Number of Total Patients Enrolled: 20
Average Percent of Total Patients Randomized: 75%
Average Percent of ‘Completed’ Studies that met Enrollment Goals: 80%
EDC Capabilities: Yes

Staff Certifications
Number of Certified CRCs: 9

ACRP Certifications
Number of ACRP Certified CRCs: 7


Established in 1995, Austin Heart Research "Center for Advanced Cardiovascular Medicine and Research", a division of St. David's Heart and Vascular, provides research services to Austin Heart regional offices throughout central Texas, the Heart Hospital of Austin, Round Rock Medical Center, and Central Texas Medical Center.

Austin Heart’s clinical research program is dedicated to providing the most innovative and progressive care to our patients, while at the same time, contributing to the science of medicine through the conduct of clinical trials.


Austin Heart offers patients the opportunity to participate in clinical trials across a wide spectrum of cardiology, including:

  • Coronary Intervention – Drug & Device Trials
  • Stem cells – MI, Peripheral and CHF
  • Peripheral Intervention – Drug & Device Trials
  • Hyperlipidemia
  • Atrial Fibrillation – Drug & Device Trials
  • Congestive Heart Failure – Drug & Device Trials
  • Valve Disease in low risk (TAVR vs. SAVR) to high risk patients (TAVR)
  • Carotid stents
  • Acute Coronary Syndrome / NSTEMI
  • Renal Denervation
  • Left Atrial Appendage Closure


Austin Heart has 19 regional offices throughout Central Texas, covering an area the size of Rhode Island. With 4 dedicated offices for research (Central Austin, Round Rock, Harker Heights [Killeen], and San Marcos), and more than 20 years of national and international research experience, Austin Heart is known throughout the research industry for quality, dependability, and stability. Austin Heart physicians are currently involved in over 50 trials ranging from local investigator-initiated pilot studies to landmark multi-center international trials. Our research encompasses all disciplines of cardiology, including:

  • Peripheral and coronary angiogenesis, including research involving gene transfer, growth factors and stem cell therapy;
  • Stem cell therapy for limb salvage in patients with peripheral arterial occlusive disease and myocardial repair in patients with recent myocardial infarction.

Accomplishments and contributions to science:

  • Austin Heart was chosen as one of only 10 sites in the United States for Phase 1 stem cell research for patients with myocardial infarction
  • Austin Heart was the first among all centers worldwide to enroll a Phase 2 study patient
  • Major contributions to the validation of the use of stents versus traditional endarterectomy surgery for the treatment of carotid artery stenosis;
  • Austin Heart is one of 40 centers participating in both Renal Artery Ablation for Resistant Hypertension and Renal Artery Stenting for Stenosis
  • Advancing diagnostic testing capability through advanced lab testing, genetic studies;
  • Nuclear/PET testing, intra-vascular ultrasound (IVUS), and optical coherence tomography (OCT);
  • Testing new medications for hyperlipidemia, atherosclerosis, congestive heart failure, anti-coagulation, and anti-platelet therapy.


Roger Gammon, MD – Principal Investigator in the following areas:
Antiplatelet Therapy, Coronary stents, ACS, Angiogenesis – Coronary & Peripheral, AMI, HIT, Distal Protection Devices, Hyperlipidemia, RF guided ablation for CTO’s – Coronary & Peripheral, Cryo Balloons, Anti-Inflammatory Agents – ACS, Drug Eluting Stents – Coronary & Peripheral, Restenosis Prevention – Drug, Atherectomy, Stem Cells – Coronary & Peripheral, CLI & Limb Salvage, DAPT, Vascular Closure Devices, Drug Coated Balloons, & OCT

Frank Zidar, MD – Principal Investigator in the following areas:
Antiplatelet Therapy, Carotid stents, Coronary stents, ACS, Atherectomy, Peripheral stents, Renal Denervation, Distal Protection Devices, Drug Eluting Stents – Coronary, OCT & TAVR

Mark Picone, DO – Principal Investigator in the following areas:
Antiplatelet Therapy, Hyperlipidemia, Atherectomy & Anti-Inflammatory Agents – ACS

Matthew Selmon, MD – Principal Investigator in the following areas:
CTO Intervention – Peripheral & Bifurcation stent

Juhana Karha, MD – Principal Investigator in the following areas:
Antiplatelet Therapy in Peripheral Interventions & TAVR

Kunjan Bhatt, MD – Principal Investigator in the following areas:
Congestive Heart Failure

Craig Siegel, MD – Principal Investigator in the following areas:
Antiplatelet Therapy, A-Fib, Hyperlipidemia, CHF, ACS, Anti-Inflammatory Agents – ACS, DES – Coronary, Anticoagulant – Coronary Intervention & DAPT

Jerry Gilbert, MD – Principal Investigator in the following areas:
Peripheral Intervention, Antiplatelet Therapy

William Abide, MD – Principal Investigator in the following areas:
Hyperlipidemia, Antiplatelet Therapy & CHF


Benjamin Vouk, CCRC, Clinical Research Director, 11 years research experience.

Mary Fraser, CCRC, Regulatory Specialist, 17 years research experience.

Paige Musick, RN, CCRC, Clinical Research Coordinator, 11 years research experience.

Alicia Bauman, RN, CCRP, Clinical Research Coordinator, 24 years research experience.

Noona TIlton, RN, CCRC, Clinical Research Coordinator, 4 years research experience.

Shannon Juarez, CCRC, Clinical Research Coordinator, 11 years clinical research experience.

Kevin Bacon, RT(r), RCIS, CRC, Clinical Research Coordinator, 2 year research experience


Austin Heart uses SDHIRB (St. David’s Hospital Institutional Review Board) and Central IRBs when available

Contact Center

If you are interested in contacting this center to discuss clinical trials, please complete and send the email form below. A representative from the research center will then follow up with you.